U.S. Markets open in 8 hrs 18 mins
  • S&P Futures

    4,134.75
    -18.75 (-0.45%)
     
  • Dow Futures

    32,986.00
    -169.00 (-0.51%)
     
  • Nasdaq Futures

    14,000.50
    -34.50 (-0.25%)
     
  • Russell 2000 Futures

    2,217.00
    -13.60 (-0.61%)
     
  • Crude Oil

    71.91
    +0.27 (+0.38%)
     
  • Gold

    1,772.40
    +3.40 (+0.19%)
     
  • Silver

    25.89
    -0.08 (-0.30%)
     
  • EUR/USD

    1.1867
    +0.0001 (+0.0119%)
     
  • 10-Yr Bond

    1.4500
    0.0000 (0.00%)
     
  • Vix

    20.70
    +2.95 (+16.62%)
     
  • GBP/USD

    1.3800
    -0.0009 (-0.0635%)
     
  • USD/JPY

    109.8200
    -0.3300 (-0.2996%)
     
  • BTC-USD

    34,282.28
    -1,590.13 (-4.43%)
     
  • CMC Crypto 200

    849.19
    -90.75 (-9.65%)
     
  • FTSE 100

    7,017.47
    -135.96 (-1.90%)
     
  • Nikkei 225

    27,897.40
    -1,066.68 (-3.68%)
     

Exact Sciences Beat Expectations in Q1: Why Investors Didn't Jump for Joy

·3 min read
Exact Sciences Beat Expectations in Q1: Why Investors Didn't Jump for Joy
  • Oops!
    Something went wrong.
    Please try again later.

Exact Sciences (NASDAQ: EXAS) hasn't delivered the sizzling performance so far in 2021 that it did last year. Exact Sciences announced its first-quarter results after the market closed Tuesday. Here are the highlights from Exact Sciences' Q1 update.